Home > Marketing > Global Drug Discovery Services Market

Global Drug Discovery Services Market

Added: (Tue Feb 19 2019)

Pressbox (Press Release) - Global Drug Discovery Services Market is expected to reach USD 18.15 Billion by 2024 from USD 7.52 Billion in 2016 at CAGR of 11.64%.

Increasing research & development expenditure, increasing patient pool, unmet medical needs, patent expiration of blockbuster drugs, enhancing regulatory framework, government assistance, rising funding & reimbursement, increasing demand for outsourcing of analytical testing and clinical trial services, inclination of major pharmaceutical companies towards outsourcing to avoid hurdles, growing awareness about chronic diseases, is driving the drug discovery services market
Process segment of drug discovery services is segmented into target selection, target validation, and hit-to-lead identification. Hit-To-Lead identification is anticipated to lead maximum share. Research based on the high-throughput screening (HTS) is the main factor driving the use of hit-to-lead identification process

Medicinal chemistry, biology services, and drug metabolism and pharmacokinetics. Medicinal chemistry segment is expected to dominate the market during the forecast period, owing to increasing number of drug discovery and developmental activities, and increasing inclination of pharmaceutical companies towards outsourcing.

Drug type segment is bifurcated as small molecules and biologics. Small molecules are more preferred than biologics. Small molecules are easy to characterize, simple and well defined. Small molecules can easily enter cells, and can cause cancer cells to die hence is leading drug discovery services market.

Geographically, North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. North America is expected to dominate the drug discovery services market in the forecast period followed by Europe and the Asia Pacific. Technologically advanced research platforms existence and early adoption of highly developed technologies and a supportive economic structure will fuel the drug discovery services market in the North America region.

Scope of the Report:

Drug Discovery Services Market, By Process:

Target Selection
Target Validation
Hit-To-Lead Identification
Lead Optimization
Candidate Validation

Drug Discovery Services Market, By Therapeutic Area:

Oncology
Neurology
Cardiovascular Diseases
Respiratory Disorders
Diabetes
Other Therapeutic Areas

Drug Discovery Services Market, By Drug Type:

Small Molecules
Biologics

Drug Discovery Services Market, By Type:

Medicinal Chemistry
Biology Services
Drug Metabolism and Pharmacokinetics (DMPK)

Drug Discovery Services Market, By Geography:

North America
Europe
Asia Pacific
Middle East & Africa
Latin America

Key Players in the Drug Discovery Services Market:

GE Healthcare
Albany Molecular Research, Inc. (AMRI)
Pharmaceutical Product Development, LLC. (Ppd)
Syngene
Wuxi Apptec
Galapagos NV
Aurigene Discovery Technologies
Genscript Biotech Corporation
WIL Research Laboratories LLC
Covance
Jubilant Biosys
Evotec
Charles River Laboratories International
Merck
Thermo Fisher Scientific
For more information visit:
Global Drug Discovery Services Market
This report publish by Maximize Market Research Company

Submitted by:9607195908
Disclaimer: Pressbox disclaims any inaccuracies in the content contained in these releases. If you would like a release removed please send an email to remove@pressbox.com together with the url of the release.